Organ support & nutrition

Trajectories of fluid management after the initiation of renal replacement therapy in critically ill patients: a secondary analysis of the STARRT-AKI trial

Crit CarePublished Secondary analysis of the STARRT-AKI randomised trial

Primary result · 90-day mortalityResult — go to the resultAdjusted odds ratio 0.48 CI 0.32–0.70

Authors' conclusion

Distinct CFB/NUF trajectories convey prognostic information beyond single-day fluid balance or NUF values

Study context

Population
Critically ill patients in the standard-strategy arm of STARRT-AKI who initiated renal replacement therapy (RRT)included in primary analysis
Participants
855 patients
Comparison
Cumulative fluid balance (CFB)/net ultrafiltration (NUF) trajectory class B vs class A
Methodological detailslatent trajectory analysis, multivariable joint longitudinal models
  • Latent trajectory analysis
  • Multivariable joint longitudinal models

Primary result

90-day mortality · 90 days

Adjusted odds ratio

0.48

CI 0.32–0.70

P < 0.001

By group

Class B vs Class A
aOR 0.48 (CI 0.32–0.70); P < 0.001

As reported in the abstract

Further findings

Higher CFB and mortality, time-dependent (Class A)

aHR (95% CI)P value
Higher CFBOnly in class A trajectory1.29 (1.03–1.55)P = 0.03

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Trajectories of fluid management after the initiation of renal replacement therapy in critically ill patients: a secondary analysis of the STARRT-AKI trial. Crit Care. Published 27 May 2025. doi:10.1186/s13054-025-05447-y

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.